MMP3 and myeloid sarcoma: Immunohistochemical analysis and in situ hybridization studies revealed that expression of fibronectin‐degrading proteinases MMP3 and MMP7 is enhanced in active demyelinating MS lesions (Anthony et al., 1997; Cossins et al., 1997; Lindberg et al., 2001).